middle.news
Algorae Launches Five Generic Oncology Drugs in ANZ via Exclusive Sakar Deal
9:02am on Tuesday 23rd of September, 2025 AEST
•
Pharmaceuticals
Read Story
Algorae Launches Five Generic Oncology Drugs in ANZ via Exclusive Sakar Deal
9:02am on Tuesday 23rd of September, 2025 AEST
Key Points
Exclusive licensing agreement with Sakar Healthcare signed
Launch of five generic oncology medicines in Australia and New Zealand
Addressable market estimated at $10 million annually
Regulatory planning underway for TGA approval
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Algorae Pharmaceuticals (ASX:1AI)
OPEN ARTICLE